ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650289; 2) Community: the network communities that were significantly associated with the response to NSC 650289; 3) Molecule: the relationships between components within communities and NSC 650289; 4) MDR: the compounds that were significantly associated with the NSC 650289.

NSC Compound Enrichment Correlation
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0137891122538509 0.30918097
NSC 77038 WR 141 0.0137891122538509 -0.21501456
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.013789112253851 -0.063699523
NSC 114346 Null 0.013789112253851 0.077032307
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.013789112253851 -0.10844787
NSC 339137 PHYSALOLACTONE 0.013789112253851 -0.049191808
NSC 624657 ANTINEOPLASTIC-624657 0.013789112253851 -0.099313398
NSC 134725 K-33 0.0171490505199911 0.10663769
NSC 295642 Null 0.0171490505199911 -0.39442531
NSC 407806 .delta.20:22-3,14,21-Trihydroxynorcholenic acid lactone 0.0171490505199911 0.24485744
Total:61  Current:19    [First] [Prev] [Next] [Last]